Watchlist Price Alert

Galectin Therapeutics Inc... (GALT)

NASDAQ: GALT · Real-Time Price · USD

3.29

0.90 (37.66%)

At close: Jun 18, 2025, 3:59 PM

Galectin Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-47.05M	-41.07M	-38.78M	-30.53M	-23.46M	-13.29M	-13.9M	-16.23M	-21.44M
Depreciation & Amortization	37K	33K	32K	41K	36K	35K	n/a	1K	7K
Stock-Based Compensation	2.45M	2.26M	2.87M	2.08M	1.8M	1.68M	4.45M	1.1M	2.48M
Other Working Capital	4.36M	2.01M	724K	65K	-1.59M	-356K	19K	8K	122K
Other Non-Cash Items	512K	1.13M	-147K	351K	87K	87K	348K	45K	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	2.28M	4.68M	4.97M	3.75M	942K	641K	-1.07M	-804K	2.54M
Operating Cash Flow	-41.77M	-32.97M	-31.06M	-24.31M	-20.6M	-10.85M	-10.18M	-15.89M	-16.41M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	30M	30M	10M	30M	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	845K	671K	899K	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	-91K	n/a	-97K	-171K	-137K	-394K	-915K	-1.23M	-741K
Other Financial Acitivies	1.23M	10.03M	97K	171K	137K	n/a	915K	1.23M	741K
Financial Cash Flow	31.23M	40.03M	10M	36.81M	263K	50.08M	15.38M	3.58M	5.92M
Net Cash Flow	-10.54M	7.07M	-21.06M	12.51M	-20.34M	39.23M	5.2M	-12.31M	-10.48M
Free Cash Flow	-41.77M	-32.97M	-31.06M	-24.31M	-20.6M	-10.85M	-10.18M	-15.89M	-16.41M